Telemedicine takes on lymphoma: a 350-Patient trial

NCT ID NCT03336138

Completed Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether using telemedicine (remote doctor visits) can improve how aggressive lymphomas are managed. The main goal was to see if patients got the right amount of chemotherapy on time. 350 patients from 10 hospitals took part. The study compared telemedicine support to usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHOMA

Contacts and locations

Locations

Bayonne Hospital

Bayonne, 64000, France
Clinique Claude Bernard

Albi, 81000, France
Clinique Marzet

Pau, 64000, France
Clinique Saint Jean

Toulouse, 31000, France
Hospital

Auch, 32000, France
Hospital

Montauban, 82000, France
Rodez Hospital

Rodez, 12000, France
Tarbes Hospital

Tarbes, 65000, France
University Hospital Bordeaux

Bordeaux, 33000, France
University Hospital of Toulouse

Toulouse, France, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.